Novo Nordisk reported DKK4.43B in Ordinary Share Capital for its fiscal quarter ending in June of 2026.





Ordinary Share Capital Change Date
Bausch Health Companies USD 373.9M 436K Jun/2026
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Eli Lilly USD 943.5M 3.33M Mar/2026
GlaxoSmithKline GBP 4.08B 20.6M Jun/2026
Merck USD 2.47B 4.93M Mar/2026
Novartis USD 1.9B 7.38M Jun/2026
Novo Nordisk DKK 4.43B 13.25M Jun/2026
Novo Nordisk DKK 4.43B 13.25M Jun/2026
Pacira USD 39.82M 512K Jun/2026
Sanofi EUR 1.21B 8.25M Mar/2026
Supernus Pharmaceuticals USD 58.16M 124K Jun/2026